No abstract

No abstract

No abstract

Two patients with proximal subclavian artery stenosis and "subclavian steal syndrome" by clinical and arteriographic criteria were treated with percutaneous transluminal balloon catheter angioplasty. Successful dilatation was obtained, but stenoses recurred at or near the dilated segments in both cases, necessitating repeat transluminal angioplasty. One patient eventually underwent surgical carotid-subclavian grafting. Factors influencing recurrent stenosis after transluminal angioplasty are discussed, including the choice of an optimal balloon inflation diameter, the pathophysiology of angioplasty, and the role of anticoagulation. Transluminal angioplasty may be a viable therapeutic alternative to operation in selected patients with occlusive subclavian disease.

While significant investments are made across the industry and increasingly also in academia to enhance or build a compound file, the efficient sourcing of compounds from in-house medical chemistry is frequently seen as a challenge. This article introduces the Compound Hub strategy developed at the Novartis Compound Archive. Central Compound Hubs in Basel and Cambridge were combined with web-based ordering of compounds and assays, providing assay-ready, solubilized samples to labs anywhere in the global research organization. Relieving scientists from time-intensive sample preparation tasks, error rates could be reduced through electronic processing and tracking of compounds/assays and the capture of medicinal chemistry compounds for the compound library could be increased by 75%.